SCHEMBL15345487

SCHEMBL15345487

Cc1cc(CN)c2ccccc2c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.55
CYP1A2 P05177 3/20 0.55
HTR2A P28223 1/20 0.50
LOXL2 Q9Y4K0 2/20 0.42
TDP1 Q9NUW8 1/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
TACR1 P25103 1/20 0.39
IDH1 O75874 1/20 0.39
CYP2D6 P10635 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HIF1A Q16665 1/20 0.37
CYP1B1 Q16678 1/20 0.37
HSD17B10 Q99714 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16041939 0.83 CYP1A2 (0.59) CYP2A6CYP1A2HTR2ATDP1CYP2C19
SCHEMBL27477260 0.83 CYP1A2 (0.59) CYP2A6CYP1A2HTR2ATDP1CYP2C19
SCHEMBL6366270 0.82 CYP1A2 (0.57) CYP2A6CYP1A2HTR2ATDP1CYP2C19
SCHEMBL19799060 0.82 CYP1A2 (0.57) CYP2A6CYP1A2HTR2ATDP1CYP2C19
SCHEMBL21119430 0.80 CYP1A2 (0.55) CYP2A6CYP1A2HTR2ATDP1CYP2C19
Ammonia Solution, Strong SCHEMBL28805674 0.80 CYP1A2 (0.55) CYP2A6CYP1A2HTR2ATDP1CYP2C19
SCHEMBL1287560 0.80 CYP1A2 (0.55) CYP2A6CYP1A2HTR2ATDP1CYP2C19
SCHEMBL8467546 0.80 CYP1A2 (0.55) CYP2A6CYP1A2HTR2ATDP1CYP2C19
SCHEMBL28440453 0.80 CYP1A2 (0.55) CYP2A6CYP1A2HTR2ATDP1CYP2C19
SCHEMBL5432013 0.78 CYP1A2 (0.53) CYP2A6CYP1A2HTR2ATDP1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3242872-B1 (PIPERIDIN-3-YL)(NAPHTHALEN-2-YL)METHANONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE HISTONE DEMETHYLASE KDM2B FOR THE TREATMENT OF CANCER GENENTECH INC (US) 2019-07-03 EP disclosed
EP-2657214-B1 PROCESS FOR PRODUCTION OF AROMATIC ALCOHOL OR HETEROCYCLIC AROMATIC ALCOHOL MITSUBISHI GAS CHEMICAL CO (JP) 2017-02-15 EP disclosed
WO-2016112284-A1 (PIPERIDIN-3-YL)(NAPHTHALEN-2-YL)METHANONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE HISTONE DEMETHYLASE KDM2B FOR THE TREATMENT OF CANCER GENENTECH, INC. (US) 2016-07-14 WO disclosed
US-8993774-B2 Process for production of aromatic alcohol or heterocyclic aromatic alcohol MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2015-03-31 US disclosed
US-20130303775-A1 PROCESS FOR PRODUCTION OF AROMATIC ALCOHOL OR HETEROCYCLIC AROMATIC ALCOHOL MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-11-14 US disclosed
EP-2657214-A1 PROCESS FOR PRODUCTION OF AROMATIC ALCOHOL OR HETEROCYCLIC AROMATIC ALCOHOL Mitsubishi Gas Chemical Company, Inc. (JP) 2013-10-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303775-A1 PROCESS FOR PRODUCTION OF AROMATIC ALCOHOL OR HETEROCYCLIC AROMATIC ALCOHOL ADH1C, ADH1A, ADH5 CYP2A6 278/4885CYP1A2 98/4885HTR2A 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.